Dentalline.de


I – Identification of the Substance and of the Company
303-592-8200
Product Grade / Name:
ORTHODONTIC ADHESIVE


II – Composition / Information on Ingredients
Aromatic and Aliphatic Dimethacrylate Monomers, Benzoyl Peroxide, 2.6 Di-Tert Butyl-P-Cresol (BHT), Silicon Dioxide Aromatic and Aliphatic Dimethacrylate Monomers, Methacrylate Monomers, Tertiary Amine Aromatic and Aliphatic Dimethacrylate Monomers, Methacrylate Monomers, Camphorquinone, Tertiary Amine
III – Hazards Identification
Incompatibility with high temperatures and strong oxidizing agents. Repeated contact with skin may cause irritation and reddening. Not likely under normal use. Mild irritant.
IV – First Aid Measures
Remove to fresh air if there are any breathing difficulties. Flush with copious amounts of water. Consult with Physician. Seek medical attention, no adverse effects expected.
V – Fire Fighting Measures
Flash Point: Not determined. Flammable Limit: Not determined. Extinguishing Media: CO2, Dry Chemical Foam Special Fire Fighting Procedures: Wear pressure demand, self-contained breathing apparatus, MSHA/NIOSH – Approved or equivalent, and full protective gear. Use water spray to cool containers. Unusual Fire and Explosion hazards: Heat can cause polymerization with rapid release of energy which may rupture container. Oxides of carbon released during thermal decomposition.
VI – Accidental Release Measures
Gloves and eye protection are suggested. Absorb small spills with a paper towel. Dike large spills with vermiculite or similar absorbent. Dispose of in an approved container.
VII – Handling and Storage
Store away from food and beverages. Store at or below room temperature away from visible light sources. Avoid contact of liquid or paste with skin, tissue, gums, and eyes. Keep containers tightly closed when not in use.
VIII – Exposure Controls / Personal Protection
Respiratory: None required under normal use. Protective Gloves: Recommended Eye Protection: Safety glasses or splash goggles Other Protective Clothing or Equipment: Lab coat
IX – Physical and Chemical Properties
Boiling Point: Not determined Vapor Pressure (mmHg): Not determined Vapor Density (Air = 1): Not determined Solubility in Water: Negligible Appearance and Odor: Creamy, off-white resin paste with an acrylic odor. Specific Gravity (H2O = 1): >1 Melting Point: Not determined Autoignition Temperature: Not determined
X – Stability and Reactivity
Conditions to Avoid: High Temperatures and visible light. Material to Avoid: Oxidizing Agents, reducers, free-radical initiators, heavy metal ions and polymerization catalysts. None under normal conditions. Oxides of Carbon when Burned. Conditions to Avoid: High Temperatures, Visible Light Sources, Open Flames.
XI – Toxicological Information

XII – Ecological Information
May cause adverse environmental impact if material reaches waterways.
XIII – Disposal Considerations
Dispose of in accordance with Federal, State, and Local Regulations. XIV – Transportation Information

XV – Regulatory Information
The product is a Class II medical device, regulated by Food and Drug Administration, United States, and is shipped as a non-regulated product by Department of Transportation Regulations. R-Phrase: R21/22: Harmful in contact with skin and if swallowed. S24/25: Avoid contact with skin and eyes.
XVI – Other Information
Note: While the information and recommendations set forth on this data sheet are believed to be accurate as received from our suppliers, RMO, Inc. makes no warranty with respect thereto and disclaims all liability from reliance thereon.

Source: http://www.dentalline.de/uploads/media/35-Monnolok_lichthaertend_Primer.pdf

Deterioro cognitivo en pacientes epilepticos

Revista Argentina de Neuropsicología 2, 1-14 (2004) Deterioro cognitivo en pacientes epilépticos Deterioro cognitivo en pacientes epilépticos Servicio de Neurología, Hospital Borda - Facultad de Medicina, UBA Los hallazgos de los Tests Neuropsicológicos en enfermos epilépticos se hallan influenciados porel/las áreas cerebrales comprometidas, el tipo de lesión (si la hubiere), la

Results on the implementation of a domperidone-based treatment program for the prevention of canine leishmaniosis in a dog kennel

RESULTS ON THE IMPLEMENTATION OF A DOMPERIDONE-BASED Gómez-Ochoa P, Llinás J, Sabaté D, Homedes J. and Ferrer, L It is widely recognised that in canine leishmaniosis the dog’s immune system plays a pivotal role both in the establishment and in the progress of infection. Indeed, protective immunity to the disease is associated with the production of an effective cell-mediated immune respo

© 2010-2018 Modern Medicine